REVIEW ARTICLE
E-cadherin/CD34 double immunostaining in placental diagnosis
 
 
More details
Hide details
1
Division of Pathology, Cincinnati Children’s Hospital, Cincinnati, United States
 
 
Submission date: 2024-03-24
 
 
Acceptance date: 2024-06-05
 
 
Publication date: 2024-09-04
 
 
Corresponding author
Jerzy Stanek
Division of Pathology, Cincinnati Children’s Hospital, Cincinnati, United States
 
 
Pol J Pathol 2024;75(3):171-181
 
KEYWORDS
TOPICS
ABSTRACT
Placental foetal vascular malperfusion (FVM) may be responsible for complicated foetal or neonatal condition. By highlighting endothelial fragmentation, the double E-cadherin/CD34 immunostain highlights distal villous endothelial fragmentation of recent FVM not seen on haematoxylin-eosin stained sections. We routinely perform the stain on a grossly unremarkable placental sections of placentas predominantly from pregnancies with mass-forming foetal anomalies and umbilical cord complications. The stain can upgrade the FVM and/or reveal its temporal heterogeneity, both useful in establishing the cause of foetal death or poor neonatal condition. It also highlights the basement membranes of syncytiotrophoblastic cells which, in conjunction with endothelial staining, is helpful in the diagnosis of widening thereof in distal villous hypomaturity. It can distinguish mineralised stem occluding thrombi from mineralised trophoblastic pseudo inclusions – the former outlined by CD34, the latter by E-cadherin – thus helping to differentiate FVM from placental aneuploidies. The E-cadherin component helps in the diagnosis of trophoblastic lesions of shallow placental implantation featuring an increased number of extravillous trophoblasts in placental membranes and chorionic disc. Therefore, the double immunostain is helpful in histological diagnosis of placental lesions and patterns of injury.
REFERENCES (30)
1.
Fox H, Sebire NJ. Pathology of the placenta. Saunders, London 2007.
 
2.
Heerema-McKenney A, Popek EJ, DePaepe ME (eds). Diagnostic pathology: placenta. Amirsys, Elsevier, Philadelphia 2019, second ed.
 
3.
Roberts DJ, Polizzano C. Atlas of placental pathology. American Registry of Pathology, Arlington, Virginia 2021.
 
4.
Redline RW, Ravishankar S, Bagby CM, Saab ST, Zarei S. Four major patterns of placental injury: a stepwise guide for understanding and implementing the 2016 Amsterdam consensus. Modern Pathol 2021; 34: 1074-1092.
 
5.
Polnaszek BE, Clark SL, Rouse DJ. Pathologic assessment of the placenta. Evidence compared with tradition. Obstet Gynecol 2022; 139: 660-667.
 
6.
Stanek J. Hypoxic patterns of placental injury: a review. Arch Pathol Lab Med 2013; 137: 706-720.
 
7.
Stanek J, Abdaljaleel M. CD34 immunostain increases the sensitivity of placental diagnosis of fetal vascular malperfusion in stillbirth. Placenta 2019; 77: 30-38.
 
8.
Stanek J, Drach A. Placental CD34 immunohistochemistry in fetal vascular malperfusion in stillbirth. J Obstet Gynaecol Res 2022; 48: 719-728.
 
9.
Stanek J. Fetal vascular malperfusion. Arch Pathol Lab Med 2018; 142: 679-680.
 
10.
Stanek J. CD34 immunostain increases the sensitivity of placental examination for distal fetal vascular malperfusion in liveborn infants. Placenta 2023; 140: 117-124.
 
11.
Stanek J. Distal villous lesions are clinically more relevant than proximal large muscular vessel lesions of placental fetal vascular malperfusion. Histol Histopathol 2022; 37: 365-372.
 
12.
Stanek J. Grading fetal vascular malperfusion and short-term perinatal outcome. Pol J Pathol 2020; 71: 291-300.
 
13.
Stanek J. Temporal heterogeneity of placental segmental fetal vascular malperfusion: timing but not etiopathogenesis. Virchows Arch 2021; 478: 905-914.
 
14.
Stanek J. Placental hypoxic overlap lesions: a clinicoplacental correlation. J Obstet Gynaecol Res 2015; 41: 358-369.
 
15.
Khong TY, Mooney EE, Ariel I, et al. Sampling and definitions of placental lesions. Amsterdam placental workshop group consensus statement. Arch Pathol Lab Med 2016; 140: 698-713.
 
16.
Breaux A, Malik F, Bernieh A, Stanek J. SARS-CoV2 placental infections and relationship to distal villous fetal vascular malperfusion. United States and Canadian Louisiana, Abstract Nr. 2598.
 
17.
Genest DR. Estimating the time of death in stillborn foetu- ses: II. Histologic evaluation of the placenta; a study of 71 stillborns. Obstet Gynecol 1992; 80: 585-592.
 
18.
Stanek J. Segmental villous mineralization: a placental feature of fetal vascular malperfusion. Placenta 2019; 86: 20-27.
 
19.
Mutema G, Stanek J. Increased prevalence of chorangiosis in placentas from multiple gestation. Am J Clin Pathol 1997; 108: 341.
 
20.
Mutema G, Stanek J. Numerical criteria for the diagnosis of placental chorangiosis using CD34 immunostaining. Trophoblast Research 1999; 13: 443-452.
 
21.
Kingdom JC, Kaufmann P. Oxygen and placental villous development: origins of fetal hypoxia. Placenta 1997; 18: 613-621.
 
22.
Stanek J. Chorangiosis of chorionic villi: what does it really mean? Arch Pathol Lab Med 2016; 140: 588-593.
 
23.
Stanek J. Membrane microscopic chorionic pseudocysts are associated with increased amount of placental extravillous trophoblasts. Pathology 2010; 42: 125-130.
 
24.
Stanek J. Chorionic disc extravillous trophoblasts in placental diagnosis. Am J Clin Pathol 2011; 136: 540-547.
 
25.
Stanek J. Placenta creta: a spectrum of lesions associated with shallow placental implantation. Obstet Gynecol Int 2020; 4230451: 1-8.
 
26.
Stanek J. Shallow placentation: a distinct category of placental lesions. Am J Perinatol 2023; 40: 1328-1335.
 
27.
Higgins M, McAuliffe FM, Mooney EE. Clinical associations with a placental diagnosis of delayed villous maturation: a retrospective study. Pediatr Dev Pathol 2011; 14: 273-279.
 
28.
Higgins M, Felle P, Mooney EE, Bannigan J, McAuliffe FM. Stereology of the placenta in type 1 and type 2 diabetes. Placenta 2011; 32: 564-569.
 
29.
Stallmach T, Hebisch G, Meier K, Dudenhausen J, Vogel M. Rescue by birth: defective placental maturation and late fetal mortality. Obstet Gynecol 2001; 97: 505-509.
 
30.
Stallmach T, Hebisch G. Placental pathology: its impact on explaining prenatal and perinatal death. Virchows Arch 2004; 445: 9-16.
 
eISSN:2084-9869
ISSN:1233-9687
Journals System - logo
Scroll to top